New hope for anemia in leukemia: targeted drug shows promise
NCT ID NCT04657094
First seen May 13, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study tests a drug called acalabrutinib in people with chronic lymphocytic leukemia (CLL) who also have a type of anemia (AIHA) that came back or didn't get better with standard treatment. The drug works by blocking certain enzymes that help cancer cells grow. The main goal is to see if the anemia improves after 6 cycles of treatment. Only 4 participants were enrolled, so results are very early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.